Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Your search for Sando-K returned no results
Showing 1 result for sandoz-k

  1. Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [ID6212]

    In development Reference number: GID-TA11203 Expected publication date:  21 January 2026